Macrocyclic inhibitors of hepatitis C virus

US9353103B2 · kind B2 · utility

Assignees

• Janssen Sciences Ireland UC · IE
• MEDIVIR AB · SE

Inventors

• Kenneth Alan Simmen · Tervuren, BE
• Herman Augustinus De Kock · Arendonk, BE
• Pierre Jean-Marie Bernard Raboisson · Sligo, IE
• Lili Hu · Mechelen, BE
• Abdellah Tahri · Anderlecht, BE
• Dominique Louis Nestor Ghislain Surleraux · Braine-le-Comte, BE
• Karl Magnus Nilsson · Vimmerby, SE
• Bengt Bertil Samuelsson · Skärholmen, SE
• Asa Annica Kristina Rosenquist · Huddinge, SE
• Vladimir Ivanov · Moscow, RU
• Mikael Pelcman · Ayacucho, PE
• Anna Karin Gertrud Linnea Belfrage · Huddinge, SE
• Per-Ola Mikael Johansson · Linköping, SE
• Sandrine Marie Helene Vendeville · Woluwe-Saint-Pierre - Sint-Pieters-Woluwe, BE

Key dates

• Filing date: Apr 13, 2015
• Grant date: May 31, 2016
• Expiry date: Apr 13, 2035

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Inhibitors of HCV replication of formula (I)and the N-oxides, salts, and stereoisomers, wherein each dashed line represents an optional double bond;